Patients with HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: a Real-World Study in Italy
BREAST CANCER MANAGEMENT（2023）
Key words
cyclin-dependent kinase 4/6 inhibitor,CDK4/6i,endocrine therapy,HER2-,hormone receptor-positive,HR+,human epidermal growth factor receptor 2-negative,metastatic breast cancer,real-world evidence
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined